Shire plc (SHPGY) Gets EMA Approval for VPRIV Production

Shire plc (Nasdaq: SHPGY), reports that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use has approved the production of VPRIV® (velaglucerase alfa) in its new state-of-the-art manufacturing facility at 400 Shire Way in Lexington, MA. The European Commissions decision is expected imminently.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Robo.ai names Hao Wang of Changer.ae to its board of directors
• Trustar Bank to acquire Forbright Bank branches for $750M in deposits
• Roots Corporation to go private in C$4.10-per-share deal with Marquee Brands